Table 1. Baseline patient characteristics (n=35 patients, 40 vessels).
| Age, year | 69.4±6.15 |
| Sex, n (%) Male/female | 30 (86)/5 (14) |
| Body mass index, kg/m2 | 22.6±1.9 |
| Hypertension/ACEI or ARB use, n (%) | 32 (91) /18 (51) |
| Systolic/diastolic BP, mm Hg | 134.7±13.3/73.6±9.7 |
| Diabetes mellitus/medical treatment, n (%) | 19 (54)/8 (23) |
| Fasting blood glucose, mmol/L | 6.1±1.1 |
| Hemoglobin A1c, % | 5.8±1.0 |
| Dyslipidemia/statin use, n (%) | 24 (69)/18 (58) |
| Total/LDL cholesterol, mmol/L | 4.7±0.9/2.7±0.7 |
| Triglyceride, mmol/L | 1.6±1.3 |
| HDL cholesterol, mmol/L | 1.3±0.7 |
| Smokers, n (%) | 28 (68) |
| Carotid stenosis, % | 81.8±5.7 |
| History of CVD | |
| Stroke/transient ischemic attack, n (%) | 16 (45)/6 (17) |
| Ischemic heart disease, n (%) | 22 (63) |
| ASO, n (%) | 9 (26) |
| Antiplatelet/aspirin use, n (%) | 35 (100)/33 (94) |
| Aspirin (100 mg/day) alone | 12 (34) |
| Aspirin and other antiplatelet drugs | 21 (60) |
| Clopidogrel (75 mg/day) alone | 1 (3) |
| Cilostazol (200 mg/day) alone | 1 (3) |
ACEI, angiotensin converting enzyme inhibitors; ARB, angiotensin type II receptor blockers; ASO, arteriosclerosis obliterans; CVD, cerebrovascular disease. Values indicate mean±s.d. NS indicates not significant.